Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 211882

ARAZLO (TAZAROTENE)
0.045%
Marketing Status: Prescription
Active Ingredient: TAZAROTENE
Proprietary Name: ARAZLO
Dosage Form; Route of Administration: LOTION; TOPICAL
Strength: 0.045%
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N211882
Product Number: 001
Approval Date: Dec 18, 2019
Applicant Holder Full Name: BAUSCH HEALTH AMERICAS INC
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English